Florence E. Turrentine

Florence E. Turrentine

Auto-generated profile, based on publicly available information

Florence E. Turrentine

Department of Surgery, University of Virginia, Charlottesville, VA, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in Nurse Education Today
Verified
Journal Article
Closed access
FTFlorence E. Turrentine
Florence E. Turrentine
KRKaren M. Rose
Karen M. Rose
JHJohn B. Hanks
John B. Hanks
BLBreyette Lorntz
Breyette Lorntz
JOJohn A. Owen
John A. Owen
ERErika E. Ramsdale
Erika E. Ramsdale

1 November 2019 in Diseases of the Colon & Rectum
Verified
Journal Article
Open access
THTaryn Hassinger
Taryn Hassinger
JMJ Hunter Mehaffey
J Hunter Mehaffey
AMAllison N Martin
Allison N Martin
KBKristine Bauer-Nilsen
Kristine Bauer-Nilsen
FTFlorence E Turrentine
Florence E Turrentine
THTraci L Hedrick
Traci L Hedrick
BACKGROUND: Delayed initiation of adjuvant chemotherapy negatively impacts long-term survival in patients with colorectal cancer. Colorectal enhanced recovery protocols result in decreased complications and length of stay; however, the impact of enhanced recovery on the timing of adjuvant chemotherapy remains unknown. OBJECTIVE: This study aimed to identify factors associated with on-time delivery of adjuvant chemotherapy after colorectal cancer surgery, hypothesizing that implementation of an enhanced recovery protocol would result in more patients receiving on-time chemotherapy. DESIGN: This was a retrospective cohort study comparing the rate of on-time adjuvant chemotherapy delivery after colorectal cancer resection before and after implementation of an enhanced recovery protocol. SETTINGS: The study was conducted at a large academic medical center. PATIENTS: All of the patients who underwent nonemergent colorectal cancer resections for curative intent from January 2010 to June 2017, excluding patients who had no indication for adjuvant chemotherapy, had received preoperative systemic chemotherapy, or did not have medical oncology records available were included. MAIN OUTCOME MEASURES: Patients before and enhanced recovery were compared, with the rate of on-time adjuvant chemotherapy delivery as the primary outcome. Adjuvant chemotherapy delivery was considered on time if initiated ≤8 weeks postoperatively, and treatment was considered delayed or omitted if initiated >8 weeks postoperatively (delayed) or never received (omitted). Multivariable logistic regression identified predictors of on-time chemotherapy delivery. RESULTS: A total of 363 patients met inclusion criteria, with 189 patients (52.1%) undergoing surgery after enhanced recovery implementation. Groups differed in laparoscopic approach and median procedure duration, both of which were higher after enhanced recovery. Significantly more patients received on-time chemotherapy after enhanced recovery implementation (p = 0.007). Enhanced recovery was an independent predictor of on-time adjuvant chemotherapy (p = 0.014). LIMITATIONS: The study was limited by its retrospective and nonrandomized before-and-after design. CONCLUSIONS: Enhanced recovery was associated with receiving on-time adjuvant chemotherapy. As prompt initiation of adjuvant chemotherapy improves survival in colorectal cancer, future investigation of long-term oncologic outcomes is necessary to evaluate the potential impact of enhanced recovery on survival. See Video Abstract at http://links.lww.com/DCR/B21. LA IMPLEMENTACIÓN DE UN PROTOCOLO DE RECUPERACIÓN ACELERADA SE ASOCIA CON EL INICIO A TIEMPO DE QUIMIOTERAPIA ADYUVANTE EN CÁNCER COLORRECTAL: ANTECEDENTES: El inicio tardío de la quimioterapia adyuvante afecta negativamente la supervivencia a largo plazo en pacientes con cáncer colorrectal. Los protocolos de recuperación acelerada colorrectales dan lugar a una disminución de las complicaciones y la duración de estancia hospitalaria; sin embargo, el impacto de la recuperación acelerada en el momento de inicio de quimioterapia adyuvante sigue siendo desconocido. OBJETIVO: Este estudio tuvo como objetivo identificar los factores asociados con la administración a tiempo de la quimioterapia adyuvante después de la cirugía de cáncer colorrectal, con la hipótesis de que la implementación de un protocolo de recuperación acelerada daría lugar a que más pacientes reciban quimioterapia a tiempo. DISEÑO: Estudio de cohorte retrospectivo que compara la tasa de administración de quimioterapia adyuvante a tiempo después de la resección del cáncer colorrectal antes y después de la implementación de un protocolo de recuperación acelerada. ESCENARIO: Centro médico académico grande. PACIENTES: Todos los pacientes que se sometieron a resecciones de cáncer colorrectal no emergentes con intención curativa desde enero de 2010 hasta junio de 2017, excluyendo a los pacientes que no tenían indicación de quimioterapia adyuvante, que recibieron quimioterapia sistémica preoperatoria o no tenían registros médicos de oncología disponibles. PRINCIPALES MEDIDAS DE RESULTADOS: Los pacientes se compararon antes y después de la implementación de la recuperación acelerada, con la tasa de administración de quimioterapia adyuvante a tiempo como el resultado primario. La administración de quimioterapia adyuvante se consideró a tiempo si se inició ≤8 semanas después de la operación, y el tratamiento se consideró retrasado / omitido si se inició> 8 semanas después de la operación (retrasado) o nunca fue recibido (omitido). La regresión logística multivariable identificó predictores de administración de quimioterapia a tiempo. RESULTADOS: 363 pacientes cumplieron con los criterios de inclusión, con 189 (52.1%) pacientes sometidos a cirugía después de la implementación de recuperación acelerada. Los grupos difirieron en el abordaje laparoscópico y la duración media del procedimiento; ambos factores fueron mayores después de la recuperación acelerada. Significativamente más pacientes recibieron quimioterapia a tiempo después de la implementación de recuperación acelerada (p = 0.007). La recuperación acelerada fue un factor predictivo independiente de quimioterapia adyuvante a tiempo (p = 0.014). LIMITACIONES: Diseño retrospectivo, tipo ¨antes y después¨ no aleatorizado. CONCLUSIONES: La recuperación acelerada se asoció con la recepción de quimioterapia adyuvante a tiempo. Debido a que el inicio rápido de la quimioterapia adyuvante mejora la supervivencia en el cáncer colorrectal, en el futuro será necesario investigar los resultados oncológicos a largo plazo para evaluar el impacto potencial de la recuperación acelerada en la supervivencia. Vea el Resumen en Video en http://links.lww.com/DCR/B21.

1 September 2018 in The American Journal of Surgery
Verified
Journal Article
Closed access
NENathan R. Elwood
Nathan R. Elwood
AMAllison N. Martin
Allison N. Martin
FTFlorence E. Turrentine
Florence E. Turrentine
RJR. Scott Jones
R. Scott Jones
VZVictor M. Zaydfudim
Victor M. Zaydfudim

1 October 2019 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
THTraci L. Hedrick
Traci L. Hedrick
RTRobert H. Thiele
Robert H. Thiele
THTaryn E. Hassinger
Taryn E. Hassinger
JDJean Donovan
Jean Donovan
DRDavid H. Reines
David H. Reines
FTFlorence E. Turrentine
Florence E. Turrentine
The American College of Surgeons (ACS) NSQIP Virginia Surgical Quality Collaborative (VSQC) exists to improve surgical outcomes through multi-institutional collaboration. Enhanced recovery (ER) protocols improve morbidity and reduce length of stay (LOS) after elective surgery. We hypothesized implementation of ER through VSQC would reduce postoperative complications and LOS in patients undergoing elective colectomy. Our objective was to evaluate whether standardization of care based on evidenced-based practices in healthcare settings across multiple institutions improved outcomes. In 2013, VSQC incrementally implemented ER for patients undergoing elective colectomy at participating institutions. Institutions shared protocols, order sets, educational materials, and met semi-annually to discuss progress. Risk-adjusted ACS NSQIP data (January 1, 2012 through December 31, 2016) was queried in 4 participating hospitals. The association of ER with surgical outcomes was evaluated with a before and after ER implementation analysis and multivariable logistic regression modeling with a priori selection of clinically relevant variables. There were 2,438 consecutive colectomies included in analysis (1,035 pre-ER/1,403 post-ER). In the post-ER implementation patient cohort, relatively more patients were treated laparoscopically (68%) compared with the pre-ER cohort (52%) (p < 0.001). Median LOS decreased from 5 to 4 days after ER implementation in patients undergoing open colectomy (p < 0.001), although total complications were similar in frequency (23% vs 22%). Laparoscopic patients had a reduced LOS (4 vs 3 days; p < 0.001), 30-day readmissions (12% vs 8%; p = 0.01), and total complications (16% vs 9%; p < 0.001) after ER implementation. In multivariable models, American Society of Anesthesiologists Physical Status Classification, hypertension, smoking, ER, and laparoscopy were independently associated with complication risk. Implementation of ER across VSQC was associated with reduction in LOS and complications in patients undergoing elective laparoscopic colectomy.

1 July 2020 in Journal of Surgical Research
Verified
Journal Article
Closed access
FTFlorence E. Turrentine
Florence E. Turrentine
ASAnneke T. Schroen
Anneke T. Schroen
PHPeter T. Hallowell
Peter T. Hallowell
BQBeth A. Quatrara
Beth A. Quatrara
PSPhilip W. Smith
Philip W. Smith
JHJulie A. Haizlip
Julie A. Haizlip

19 February 2020 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
PDF file
FTFlorence E. Turrentine
Florence E. Turrentine
VZVictor M. Zaydfudim
Victor M. Zaydfudim
AMAllison N. Martin
Allison N. Martin
SJScott R Jones
Scott R Jones
Elderly patients, > 65 years of age, undergo an increasing number of surgical operations performed annually in the United States and they present with unique health care needs. Preventing postoperative readmission remains an important challenge to improving surgical care. This study examined whether geriatric-specific variables were independently associated with postoperative readmissions of elderly patients. The ACS Geriatric Surgery Research File (GSRF) was joined with the ACS NSQIP PUF files for 2014-2016. This data set included 13 GSRF variables and 26 ACS NSQIP variables. Associations between clinically relevant variables and readmission were tested with multivariable logistic regression. The data represented 6,039 general surgery patients age 65 years and older. 58% of patients had colorectal operations, 19% pancreatic or hepatobiliary, 15% hernia, 4% thyroid or esophageal, and 3% had appendix operations. 24% of patients experienced a NSQIP defined 30-day postoperative complication, and 3% died within 30 days following surgery. 11% of patients had unplanned 30-day readmissions. Standard NSQIP variables including 30-day composite morbidity (OR 5.11, 95% CI 4.24-6.16, p <0.001), reoperation (OR 2.8, CI 2.07- 3.79, p <0.001), and steroid use (1.42, CI 1.03-1.96, p=0.03) were associated with readmission. In addition, GSRF variables including incompetent on admission (OR 1.63, CI 1.11-2.38, p =0.01), fall risk at discharge (OR 1.42, CI 1.11-1.82, p=0.005), use of mobility aid (OR 1.26 CI 1.02-1.56, p= 0.03), and discharged home with skilled care (OR 1.22, CI 1.0-1.49, p=0.04) were associated with readmission. Four GSRF and 3 current standard ACS NSQIP variables were important in the evaluation of postoperative readmission of elderly patients. Geriatric-specific variables contributed to the explanation of the relationship between clinical variables and readmissions in elderly surgical patients.